Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

Repeated Exposure to the “Spice” Cannabinoid JWH-018 Induces Tolerance and Enhances Responsiveness to 5-HT1A Receptor Stimulation in Male Rats

Joshua S. Elmore, Michael H. Baumann

Frontiers in Psychiatry February 27, 2018 DOI: 10.3389/fpsyt.2018.00055 (opens in new tab) via OpenAlex

Summary

AI-generated from the abstract

Repeated exposure to the synthetic cannabinoid JWH-018, found in psychoactive 'spice' products, produces tolerance to its own hypothermic and cataleptic effects in male rats, and transiently enhances sensitivity of 5-HT1A receptors, as shown by augmented behavioral and hypothermic responses to the 5-HT1A agonist 8-OH-DPAT one day after treatment cessation. However, it does not affect behaviors induced by the 5-HT2A/2C receptor agonist DOI.

Study at a glance

Characteristics Preclinical experimental study Peer reviewed
Population Male Sprague-Dawley rats
Interventions JWH-018 DOI 8-OH-DPAT
Dose 1.0 mg/kg, sc (JWH-018); 0.1 mg/kg, sc (DOI); 0.3 mg/kg, sc (8-OH-DPAT)
Duration 7 consecutive days of repeated treatment, with challenges at 1 and 7 days after the final repeated treatment
Topics Serotonin
Keywords Catalepsy 5-ht1a receptor Hypothermia Synthetic cannabinoids Cannabinoid receptor
Citations 26
Key finding Repeated JWH-018 treatment produces tolerance to its hypothermic and cataleptic effects and transiently enhances 5-HT1A receptor sensitivity, but does not alter 5-HT2A/2C receptor-mediated behaviors.

Abstract

Naphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) is a synthetic compound found in psychoactive “spice” products that activates cannabinoid receptors. Preclinical evidence suggests that exposure to synthetic cannabinoids increases 5-HT2A/2C receptor function in the brain, an effect which might contribute to psychotic symptoms. Here, we hypothesized that repeated exposures to JWH-018 would enhance behavioral responsiveness to the 5-HT2A/2C receptor agonist DOI. Male Sprague-Dawley rats fitted with sc temperature transponders received daily injections of JWH-018 (1.0 mg/kg, sc) or its vehicle for 7 consecutive days. Body temperature and catalepsy scores were determined at 1, 2 and 4 h post-injection each day. At 1 and 7 days after the final repeated treatment, rats received a challenge injection of either DOI (0.1 mg/kg, sc) or the 5-HT1A receptor agonist 8-OH-DPAT (0.3 mg/kg, sc), then temperature and behavioral responses were assessed. Behaviors induced by DOI included wet dog shakes and back muscle contractions (i.e., skin jerks), while behaviors induced by 8-OH-DPAT included ambulation, forepaw treading and flat body posture. On the first day of repeated treatment, JWH-018 produced robust hypothermia and catalepsy which lasted up to 4 h, and these effects were significantly blunted by day 7 of treatment. Repeated exposure to JWH-018 did not affect behaviors induced by DOI, but behavioral and hypothermic responses induced by 8-OH-DPAT were significantly augmented 1 day after cessation of JWH-018 treatment. Collectively, our findings show that repeated treatment with JWH-018 produces tolerance to its hypothermic and cataleptic effects, which is accompanied by transient enhancement of 5-HT1A receptor sensitivity in vivo.

Explore topics

Comments

No comments yet.

Log in to comment